Author

M. Chatziandreou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:virus· 1

Frequent Co-Authors

D. L. Hurdiss· 2 shared I. Drulyte· 2 shared A. Aggarwal· 1 shared A. Norman· 1 shared A. Zegar· 1 shared B. J. Bosch· 1 shared B.-J. Bosch· 1 shared C. A. M. de Haan· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. L. Hurdiss

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Spike Trimer Dimer-Inducing Nanobody with Anti-Sarbecovirus Activity

I. C. Swart, O. J. Debski Antoniak, A. Zegar, T. de Bouter, M. Chatziandreou, M. van den Berg, I. Drulyte, K. Pyrc, C. A. M. de Haan, D. L. Hurdiss, B.-J. Bosch, S. Oliveira

This paper describes a nanobody, 7F, that neutralizes SARS-CoV-2 and cross-neutralizes SARS-CoV and SARS-like CoV pseudoviruses by inducing spike trimer dimers and shows therapeutic potential in 3D tissue cultures.

bioRxiv · Jun 19, 2024 · PreprintMicrobiology

A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein

V. Thijssen, D. L. Hurdiss, O. J. Debski-Antoniak, M. A. Spence, C. Franck, A. Norman, A. Aggarwal, N. J. Mokiem, D. A. A. van Dongen, S. W. Vermeir, M. Liu, W. Li, M. Chatziandreou, T. Donselaar, W. Du, , S. A. K. Jongkees

This paper discovers a macrocyclic peptide that inhibits SARS-CoV-2 and related sarbecoviruses by targeting a conserved site in the spike protein, offering a potential broad-spectrum antiviral.

bioRxiv · Nov 11, 2022 · PreprintBiochemistry